MeiraGTx Holdings PLC

MGTX Healthcare Biotechnology

MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 8,608.6%, EPS grew 466.7%, free cash flow grew 13.1% and total debt rose 28.6%, each against the same quarter a year earlier.

9.28 0.61 −6.17%
Market cap
$949.9M
P/E
12.2×
Fwd P/E
−5.6×
Dividend yield
—
F-score
5/9
Altman Z
−4.39
Beneish M
−3.01
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
65.93 103.66 129.57 115.52 137.70 209.52 227.23 68.08 8.55 17.48
Receivables
18.29 9.68 23.42 29.02 35.02 51.41 35.31 3.42 — —
Inventory
— 0.39 — — — — — — — —
Other current assets
1.53 2.97 1.02 1.67 2.42 4.57 1.97 1.22 0.97 0.40
Total current assets
91.76 123.52 159.62 154.34 183.24 272.58 268.98 74.65 11.48 19.09
Property, Plant, Equpment (Net)
105.47 102.88 115.90 109.27 75.86 44.04 23.86 22.01 14.26 3.02
Long-Term Investments
6.75 6.75 6.77 6.33 6.66 — 0.12 0.12 0.12 0.44
Goodwill and Intangible Assets (Total)
0.58 0.82 1.12 1.34 1.79 2.12 0.78 — — —
Long-term assets (Other)
3.41 3.01 3.00 2.14 2.19 1.88 2.05 0.23 0.12 0.44
Total non-current assets
152.67 146.23 167.12 163.90 136.92 91.12 54.91 22.24 14.38 3.46
Total Assets
244.43 269.75 326.74 318.24 320.16 363.70 323.89 96.89 25.85 22.55
Notes Payable
24.65 — — — — — — — 1.44 —
Accounts Payable
10.07 23.59 16.04 16.62 15.35 7.13 3.76 3.04 7.06 1.47
Accrued Expenses
32.89 27.41 42.64 39.82 27.59 20.86 18.08 11.99 9.33 4.02
Current Part of Capital Lease
0.04 4.05 4.19 3.88 3.37 2.58 1.67 0.03 0.03 0.01
Current Revenue (Deferred)
1.78 4.83 2.93 15.12 21.82 23.55 25.68 — — —
Other current liabilities
50.28 0.90 1.28 6.63 49.41 0.02 43.76 0.44 3.54 0.54
Total current liabilities
122.56 60.78 67.08 82.07 68.13 54.15 49.20 15.50 21.40 6.04
Long Term Debt (Total)
49.80 73.22 85.07 88.36 20.36 19.67 21.50 0.01 0.03 0.01
Non-current Revenue (Deferred)
65.12 57.58 34.02 27.44 43.05 49.30 60.54 0.20 0.27 0.59
Long Term Tax Liability (Deferred)
— — — 0.19 0.20 0.21 0.20 — — —
Liabilities (Preferred Stock)
— — — — — — — — 51.34 32.83
Non-current Liabilities (Other)
1.40 2.82 2.40 2.44 3.03 1.81 1.65 0.13 0.18 0.22
Total non-current liabilities
127.67 141.14 121.49 118.43 66.64 70.99 83.89 0.34 51.82 33.65
Total liabilities
250.22 201.92 188.57 200.50 134.76 125.14 133.09 15.84 73.22 39.69
Additional Paid In Capital
808.02 773.57 693.84 581.89 528.66 504.48 395.63 229.05 20.08 17.90
Common Stock (Net)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
(816.22) (702.02) (554.23) (470.20) (340.59) (261.03) (203.04) (148.29) (65.42) (34.38)
Common Equity (Total)
(5.79) 67.83 138.18 117.74 185.40 238.56 190.80 81.06 (47.37) (17.14)
Shareholders Equity (Total)
(5.79) 67.83 138.18 117.74 185.40 238.56 190.80 81.06 (47.37) (17.14)
Shareholders Equity and Liabilities (Total)
244.43 269.75 326.74 318.24 320.16 363.70 323.89 96.89 25.85 22.55
Shares (Common)
81.12 78.40 63.60 48.48 44.55 44.19 36.79 27.39 8.72 8.43
Shares (Preferred)
— — — — — — — — — 1.58
Shareholders Equity (Tangible)
(6.37) 67.01 137.06 116.40 183.61 236.44 190.80 81.06 (47.37) (17.14)
Net Debt
(16.13) (30.44) (44.49) (27.15) (117.34) (189.85) (205.73) (68.07) (8.51) (17.47)
Total Debt
49.80 73.22 85.07 88.36 20.36 19.67 21.50 0.01 0.03 0.01

Fold the line items

In millions of $ except per-share values · columns are period end dates